Jacob, P; Shulgin, AT. Preparation of novel N-substituted-2-amino-3′,4′-methylenedioxypropiophenones as anti-depressant and anti-parkinsonism agents. Patent WO 1996/039133 A1, 12 Dec 1996. 941 kB.
Liu, C; Jia, W; Li, T; Hua, Z; Qian, Z. Identification and analytical characterization of nine synthetic cathinone derivatives N-ethylhexedrone, 4-Cl-pentedrone, 4-Cl-α-EAPP, propylone, N-ethylnorpentylone, 6-MeO-bk-MDMA, α-PiHP, 4-Cl-α-PHP, and 4-F-α-PHP. Drug Test. Anal., 1 Aug 2017, 9 (8), 1162–1171. 1.6 MB. https://doi.org/10.1002/dta.2136
EMCDDA. New drugs in Europe, 2016, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2017. 489 kB. #24
4-Propynyloxy-3,5-dimethoxyphenethylamine · PROPYNYL
MDMVP · Pentylone · bk-MBDP · bk-Methyl-K
Euthylone · Eutylone · MDEBP · bk-EBDB
BAT · Flyscaline · M-FLY · MeO-2C-2,6-IFLY · Mescaline-FLY
Dibutylone · MDDMBP · bk-DMBDB
N-Isopropyl-3,4-methylenedioxycathinone · iPrONE
4-Acetoxy-N-acetylamphetamine
N-Acetyl-N-methyl-3,4-methylenedioxyphenethylamine · N-Acetyl-MDMA
3,4-Methylenedioxy-N-methyl-N-ethylcathinone · MDMEC
3,4-MDO-Phendimetrazine · 3,4-Methylenedioxyphendimetrazine